Cannabis Health/LinkedIn
Mar 9, 2026, 10:16
Ananda Pharma Cleared to Launch Phase 2 Trial for Endometriosis Pain Treatment – Cannabis Health
Cannabis Health shared a post on LinkedIn:
“Ananda Pharma Ltd has cleared the final regulatory hurdle needed to begin its ENDOCAN Phase 2 clinical trial in women with endometriosis-associated pain.
The company has received approval from the MHRA and NHS Health Research Authority to commence dosing of its proprietary MRX1 CBD oral solution.
Melissa Sturgess, CEO of Ananda Pharma, said: ‘The reason this study is different is that we are using a product that could go all the way through to regulatory approval and be able to be prescribed by a doctor on the NHS.’ ”
Stay updated on all scientific advances in the field of fertility with Fertility News.
-
Sep 13, 2026, 15:11Sachintha Alwis: From Impaired Sperm Motility to Microrobotics
-
Sep 13, 2026, 15:08Laurence Orbuch: Before Endometriosis Surgery, Ask…
-
Sep 13, 2026, 15:05Ademola Ayodele: IUI, IVF or Egg Freezing – Which One Is Right for You?
-
Sep 13, 2026, 14:59Fiona Pathiraja-Møller: Tennis Players No Longer Have to Choose Between Career and Family
-
Sep 13, 2026, 14:571-Day Virtual Experience for People Impacted by PMOS – PCOS Awareness Association
-
Sep 13, 2026, 14:53Ozor Victor: Behind Every Embryo Is a Story of Science, Precision, and Hope
-
Sep 13, 2026, 14:50Diana Kayal: What They Don’t Tell You About IVF
-
Sep 13, 2026, 14:44Vikram Sinai Talaulikar: A Heartfelt Thank You to All Who Donated and Supported “Menopause and Cancer”
-
Sep 13, 2026, 14:41Nicole McPherson: Changing IVF Practices Is Hard – Integration Needs to Be Easy
